cookies-img
We use third-party cookies to provide support. By continuing to browse this website, you accept our privacy policy.
close-icon
Personalis Inc
11 own
11 watching
Current Price
$1.31
$0.02
(1.16%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Market Capitalization
Market Capitalization
98.85M
52-Week High
52-Week High
2.60000
52-Week Low
52-Week Low
0.89060
Average Volume
Average Volume
0.1M
Dividend Yield
Dividend Yield
--
P/E Ratio
P/E Ratio
--
iconMarket Capitalization98.85M
icon52-Week High2.60000
icon52-Week Low0.89060
iconAverage Volume0.1M
iconDividend Yield--
iconP/E Ratio--
What does the Personalis Inc do?
Personalis, Inc. is a growing cancer genomics company transforming the development of next-generation therapies by providing more comprehensive molecular data about each patient’s cancer and immune response. They designed their NeXT Platform to adapt to the complex and evolving understanding of cancer, providing their biopharmaceutical customers with information on all of the approximately 20,000 human genes, together with the immune system, in contrast to many cancer panels that cover roughly 50 to 500 genes. They are also developing a complementary liquid biopsy assay that analyzes all human genes versus the more narrowly focused liquid biopsy assays that are currently available. By combining technological innovation, operational scale, and regulatory differentiation, their NeXT Platform is designed to help their customers obtain new insights into the mechanisms of response and resistance to therapy as well as new potential therapeutic targets. Their platform enhances the ability of biopharmaceutical companies to unlock the potential of conducting translational research in the clinic rather than with pre-clinical animal models or cancer cell lines. They are also planning to release a diagnostic based on their NeXT Platform that they envision being used initially by biopharmaceutical customers and clinical collaborators. Since inception, they have provided their services to more than 45 biopharmaceutical customers, including several of the largest pharmaceutical companies in the world. Personalis, Inc. were incorporated under the laws of the state of Delaware in February 2011 under the name Personalis, Inc. Their principal executive offices are located at 1330 O’Brien Drive, Menlo Park, California 94025.
Read More
How much money does Personalis Inc make?
News & Events about Personalis Inc.
Business Wire
1 year ago
Personalis, Inc. (Nasdaq: PSNL), Cancer Research UKs Cancer Research Horizons, University College London (UCL), and the Francis Crick Institute today announced a collaboration to deploy NeXT Personal, a personalized liquid biopsy-based research assay, for the TRACERx study, a groundbreaking lung...
Market News Video
1 year ago
In trading on Friday, the ARK Genomic Revolution ETF is outperforming other ETFs, up about 5.3% on the day. Components of that ETF showing particular strength include shares of Pacific Biosciences of California, up about 17.9% and shares of Personalis, up about 16.5% on the day...
Business Wire
1 year ago
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, today announced it will continue its collaboration with AstraZeneca (LSE/STO/Nasdaq: AZN), a global science-led biopharmaceutical company, to explore ultra-sensitive molecular residual disease (MRD) measurement...
Business Wire
1 year ago
Personalis, Inc. (Nasdaq: PSNL), a leader in advanced genomics for precision oncology, and Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced the companies have signed a new agreement to continue using the Personalis NeXT...
Business Wire
1 year ago
Personalis, Inc. (Nasdaq: PSNL) today announced a collaboration with UC San Francisco (UCSF) that will deploy a personalized liquid biopsy-based research use only (RUO) assay for a study of patients with colorectal cancer. The research efforts will use Personalis NeXT Personal assay to evaluate...
Frequently Asked Questions
Frequently Asked Questions
What is Personalis Inc share price today?
plus_minus_icon
Can Indians buy Personalis Inc shares?
plus_minus_icon
How can I buy Personalis Inc shares from India?
plus_minus_icon
Can Fractional shares of Personalis Inc be purchased?
plus_minus_icon
What are the documents required to start investing in Personalis Inc stocks?
plus_minus_icon
What is today’s traded volume of Personalis Inc?
plus_minus_icon
What is today’s market capitalisation of Personalis Inc?
plus_minus_icon
What is the 52-Week High and Low Range of Personalis Inc?
plus_minus_icon
What percentage is Personalis Inc down from its 52-Week High?
plus_minus_icon
What percentage is Personalis Inc up from its 52-Week Low?
plus_minus_icon
Current Price
$1.31
$0.02
(1.16%)
arrow-icon
1 Week Returns
3 Months Returns
1 Year Returns

Get Started with as little as $1.00

Get Started with as little as $1.00